BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced the presentation of clinical data by Professor Raphael Bueno, M.D., Chief of Thoracic Surgery, Brigham and Women’s Hospital (BWH), Boston, and Principal Investigator of the ongoing Window of Opportunity study, in an oral presentation at the 13th International Mesothelioma Interest Group (iMig) Conference being held May 1-4, 2016 in Birmingham, UK.
